BR112016004054A2 - compositions and methods for treating nasal conditions - Google Patents
compositions and methods for treating nasal conditionsInfo
- Publication number
- BR112016004054A2 BR112016004054A2 BR112016004054A BR112016004054A BR112016004054A2 BR 112016004054 A2 BR112016004054 A2 BR 112016004054A2 BR 112016004054 A BR112016004054 A BR 112016004054A BR 112016004054 A BR112016004054 A BR 112016004054A BR 112016004054 A2 BR112016004054 A2 BR 112016004054A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- treating nasal
- nasal conditions
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ÿþrÿþr
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/010,340 US8952011B2 (en) | 2008-08-01 | 2013-08-26 | Compositions and methods for the treatment of nasal conditions |
PCT/US2014/052242 WO2015031183A1 (en) | 2013-08-26 | 2014-08-22 | Compositions and methods for the treatment of nasal conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112016004054A2 true BR112016004054A2 (en) | 2017-09-12 |
Family
ID=52587229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016004054A BR112016004054A2 (en) | 2013-08-26 | 2014-08-22 | compositions and methods for treating nasal conditions |
Country Status (4)
Country | Link |
---|---|
BR (1) | BR112016004054A2 (en) |
MX (1) | MX2016002485A (en) |
RU (1) | RU2016111112A (en) |
WO (1) | WO2015031183A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115701993A (en) * | 2020-11-20 | 2023-02-14 | 成都百裕制药股份有限公司 | Pharmaceutical compositions and formulations comprising bilobalide components and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1492554B1 (en) * | 2001-06-21 | 2019-08-21 | Althea Technologies, Inc. | Spherical protein particles |
US20120156244A1 (en) * | 2008-08-01 | 2012-06-21 | Alpha Synergy Development Inc. | Nasal Compositions and Uses Thereof |
-
2014
- 2014-08-22 WO PCT/US2014/052242 patent/WO2015031183A1/en active Application Filing
- 2014-08-22 BR BR112016004054A patent/BR112016004054A2/en not_active IP Right Cessation
- 2014-08-22 MX MX2016002485A patent/MX2016002485A/en unknown
- 2014-08-22 RU RU2016111112A patent/RU2016111112A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2016111112A (en) | 2017-09-29 |
WO2015031183A1 (en) | 2015-03-05 |
MX2016002485A (en) | 2016-11-14 |
RU2016111112A3 (en) | 2018-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016000326A1 (en) | Compositions and method to treat conditions associated with the complement | |
BR112015023679A2 (en) | immunotherapy compositions and methods | |
EP2986140A4 (en) | Compositions, methods, and kits for treatment of pets | |
BR112017011771A2 (en) | methods and compositions for cancer treatment | |
ZA201505390B (en) | Compositions and methods for treating pests | |
SG10201707319UA (en) | Compositions and methods for treating mpsi | |
BR112015028115A2 (en) | methods and compositions for cancer treatment | |
CL2015003049A1 (en) | Variants of pertuzumab and its evaluation | |
CL2015002146A1 (en) | Compositions and procedures for treating superficial wounds | |
BR112015030351A2 (en) | method and apparatus for performing local transactions | |
BR112015028572A2 (en) | axial fan | |
BR112015023511A2 (en) | tensor | |
BR112014027219A2 (en) | method | |
FI20135866L (en) | MICROBIOLOGICAL PROCESSING OF KERATIN | |
BR112014026326A2 (en) | composition for treatment of metabolic disorders | |
BR112015023782A2 (en) | pulleys set | |
BR112015032344A2 (en) | naphthyl- or isoquinolinyl-substituted isothiazoline compounds | |
BR112015016577A2 (en) | retainer and syringe | |
DK2976101T3 (en) | Treatment procedure | |
BR112015024771A2 (en) | catheter | |
BR112015025165A2 (en) | vehicle | |
BR112016004054A2 (en) | compositions and methods for treating nasal conditions | |
BR112015019792A2 (en) | hemorrhoid treatment composition and method of preparation | |
DE102014115817B8 (en) | Ionizer and control method for this | |
EP2968550A4 (en) | Compositions and methods for treating angiogenesis-related disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11N | Dismissal: publication cancelled | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2529 DE 25-06-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |